Announcement of The Consolidated Financial Report for The 2nd Quarter of 2022

2022.8.5

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2022/08/05 Time of announcement 17:58:54
Subject Announcement of The Consolidated Financial Report for The 2nd Quarter of 2022
Date of events 2022/08/05 To which item it meets paragraph 31
Statement 1.Date of the board of directors submitted or approved:2022/08/05
2.Date of the audit committee approved:2022/08/05
3.Start and end dates of financial reports or unaudited finaicial information of the reporting period:2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):2,202,632
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,367,109
6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):544,279
7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):638,274
8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):510,860
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):511,669
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):2.06
11.Total assets end of the period (thousand NTD):9,390,039
12.Total liabilities end of the period (thousand NTD):3,786,989
13.Equity attributable to owners of parent end of the period (thousand NTD):5,032,917
14.Any other matters that need to be specified:None
TOP